Skip to main content
Clinical Trials/ITMCTR2022000020
ITMCTR2022000020
Recruiting
Phase 1

A Prospective Study and mechanism exploration of Tangwang prescription in the Treatment of Non-Proliferative Diabetic Retinopathy

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Xicheng District, Beijing0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Xicheng District, Beijing
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Xicheng District, Beijing

Eligibility Criteria

Inclusion Criteria

  • (1\) Meet the diagnostic criteria for type 2 diabetic retinopathy, the degree of the disease is non\-proliferative (at least one eye meet)
  • (2\) Age 30\-70 years

Exclusion Criteria

  • (1\)Other ophthalmic diseases that do not belong to diabetic retinopathy, such as non\-diabetic retinopathy, uveitis, retinal detachment, optic nerve disease and high myopia with fundus lesions;
  • (2\)meet the diagnostic criteria for diabetic retinopathy, but the degree of the disease was proliferative.
  • (3\)Type 1 diabetic retinopathy.

Outcomes

Primary Outcomes

Not specified

Similar Trials